Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2010
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
12/29/2010CN101932550A Aromatic amine derivative and organic electroluminescent device using the same
12/29/2010CN101928288A Small molecule compositions for binding to HSP90
12/29/2010CN101928243A Acenaphtho heterocyclic compounds, and cyclodextrin inclusion compounds or conjugates thereof and application thereof in preparing Bcl-2 family protein inhibitors
12/29/2010CN101168134B Nanometer structure cinchona alkaloid thiourea multi-phase bionic catalyst and preparation method thereof
12/29/2010CN101102999B Novel process for the preparation of substituted indoles
12/29/2010CA2766618A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
12/29/2010CA2765678A1 Substituted hydroxamic acids and uses thereof
12/28/2010US7858811 1,2,3,9-tetra-hydro-carbazol-4-one; intermediate in the process for the preparation of (1-(carbazol-4-yloxy-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol or carvedilol
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858773 Process for preparing substituted benzimidazole compounds
12/28/2010US7858616 treating excessive or abnormal endothelial cell proliferation comprising administering compounds such as 3-Z-[1-(4-dimethylaminomethylanilino)-1-(3-(2-carboxyethyl)phenyl)methylene]-6-chloro-2-indolinone; antitumor, anticarcinogenic or antiproliferative agents
12/23/2010WO2010148396A1 Perindopril tosylate
12/23/2010WO2010147922A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010WO2010147318A2 Aminoanthracene derivative and an organic electroluminescent element employing the same
12/23/2010WO2010146883A1 Oxime ester compound, radical polymerization initiator, polymerizable composition, negative resist and image pattern
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2009128088A3 Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin
12/23/2010US20100325754 Compositions and methods for modulating oxidative burst in plant transformation
12/23/2010US20100324305 Production method of polycyclic lactams
12/23/2010US20100324304 Improved ramipril synthesis
12/23/2010US20100324303 Use of Tetramic Acid Derivatives for Controlling Animal Pests After Treatment of the Trunk, the Branches, the Influorescences or the Buds
12/23/2010US20100324266 Photocleavable Protecting Groups
12/23/2010US20100324108 Substituted isoindoline-1,3-dione derivatives
12/23/2010US20100324107 USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE
12/23/2010US20100324106 Compounds
12/23/2010US20100324105 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100320451 Benzochrysene derivative and organic electroluminescence device using the same
12/23/2010CA2765015A1 Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2262768A2 Preparation of lenalidomide
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2029534B1 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
12/22/2010EP1501840B1 Bridged bi-aromatic ligands, complexes, catalysts, processes for polymerizing and polymers therefrom
12/22/2010EP1412317B1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
12/22/2010CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
12/22/2010CN101925577A Salt forms of 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
12/22/2010CN101921587A Fluorescent probe having tumor cell proliferation inhibition activity and preparation method thereof
12/22/2010CN101921223A Synthesis method of indole-3-methanol
12/22/2010CN101921184A Multi-functional group type aromatic ketone compound and photoinitiator containing same
12/22/2010CN101072779B 2,4 (4,6) pyrimidine derivatives
12/21/2010US7855293 Fluorescent dyes such as 2-(4-acetanilino-1,3-butadieneyl)-3-spiro-1'-cyclohexan-1-(4-sulfobutyl)-3H -indolium hydroxide metal salts which couple biological materials without loss of fluorescence due to self-quenching
12/21/2010US7855227 2-[[2-[4-(3-Fluoro-benzyloxy)-3-methoxy-phenyl]-ethyl]-isobutylamino]-N-methyl-acetamide, useful in preventing neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urogenital and gastrointestinal disorders
12/21/2010US7855225 17βHSD type 5 inhibitor
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010CA2580833C Method of preparing poly(adp-ribose) polymerases inhibitors
12/21/2010CA2406255C Hydroxylamine esters as polymerization initiators
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142183A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010142182A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2007051081A8 Methods and compounds for preparing cc-1065 analogs
12/16/2010US20100317966 Hybrid-multimodal magneto-optical contrast markers
12/16/2010US20100317863 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010CA2764653A1 Tetracyclic compounds
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2260041A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/15/2010EP2260023A1 Fluorine derivatives for organic electroluminescence devices
12/15/2010EP2260022A1 Substituted cyclohexyldiamines
12/15/2010EP2260021A1 Substituted 4-aminocyclohexane derivatives
12/15/2010EP2114878B1 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
12/15/2010EP1634883B1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
12/15/2010EP1503985B1 Polypeptides and biosynthetic pathways
12/15/2010CN1993324B 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
12/15/2010CN101918360A Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
12/15/2010CN101914584A Method for producing L-tryptophan
12/15/2010CN101914056A Preparation method of N-alkyl substituted tetrahydro-carbazolone derivative
12/15/2010CN101914055A Reductive preparation method of imide
12/15/2010CN101914054A Comprehensive method for extracting L-tryptophan from fermentation liquor
12/15/2010CN101914053A Method for preparing indolylacetic acid and abscisic acid from seaweeds
12/15/2010CN101912693A Equipment and method for separating indole and biphenyl from wash oil fraction
12/15/2010CN101912389A Pharmaceutical composition containing ST-246 and preparation method and application thereof
12/14/2010US7851644 Heterocyclic metallocenes and polymerization catalysts
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851625 Process for preparing 2,3-disubstituted indoles
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2355939C Antihistaminic spiro compounds
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010139953A1 Compounds
12/09/2010WO2010139266A1 Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and intermediates thereof
12/09/2010WO2010120398A3 Process for preparing n-substituted cyclic imides
12/09/2010US20100311985 Indolinone derivatives and process for their manufacture
12/09/2010US20100311797 Novel Compounds
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258776A1 Fluorescent cyanine dyes containing functional groups
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2258363A1 Compositions for treatment of cancers
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 458